TipRanksTop Financial ExpertsInsidersAtlas Venture Fund XI, L.P.

Atlas Venture Fund XI, L.P. Insider Profile

4 Followers
Atlas Venture Fund XI, L.P., Ten Percent Owner at Akero Therapeutics, holds 6.56M shares in Dyne Therapeutics (Ticker: DYN), holds 2.75M shares in Xilio Therapeutics (Ticker: XLO), holds 6.01M shares in Day One Biopharmaceuticals (Ticker: DAWN).
tipranks
Atlas Venture Fund XI, L.P.

Atlas Venture Fund XI, L.P.
Akero Therapeutics (AKRO)
Ten Percent Owner

Ranked #88,338 out of 97,372 Corporate Insiders

Profitable Transactions

38%
3 out of 8 Profitable Transactions

Average Return

-30.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$383M
49.97%
27.42%
19.67%
1.60%
1.33% Others
A breakdown of Atlas Venture Fund XI, L.P.'s holdings

Insider Roles

Dyne Therapeutics
(DYN)
Ten Percent Owner
Day One Biopharmaceuticals
(DAWN)
Ten Percent Owner
Akero Therapeutics
(AKRO)
Ten Percent Owner
Third Harmonic Bio, Inc.
(THRD)
Ten Percent Owner
+2 other positions
Roles that Atlas Venture Fund XI, L.P. holds in companies

Most Profitable Insider Trade

Stock:
Akero Therapeutics
(AKRO)
Rating:Informative Buy
Date:Jun 25, 2019 - Jun 25, 2020
Return:+39.40%
The most profitable trade made by Atlas Venture Fund XI, L.P.

Atlas Venture Fund XI, L.P.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Akero Therapeutics
Jan 02, 2020
Ten Percent Owner
Uninformative Sell
$75.27M
Dyne Therapeutics
Feb 28, 2024
Ten Percent Owner
Uninformative Sell
19.63M
$191.17M
Day One Biopharmaceuticals
Dec 14, 2022
Ten Percent Owner
Uninformative Sell
$104.91M
Xilio Therapeutics
Feb 09, 2024
Ten Percent Owner
Informative Sell
640.00
$1.98M
Ikena Oncology
Dec 14, 2021
Ten Percent Owner
Informative Sell
385.57K
$3.11M
Third Harmonic Bio, Inc.
Sep 19, 2022
Ten Percent Owner
Informative Buy
5.10M
$6.12M
List of latest transactions for each holding click on a transaction to see Atlas Venture Fund XI, L.P.'s performance on stock

Atlas Venture Fund XI, L.P. insider profile FAQ

What is the percentage of profitable transactions made by Atlas Venture Fund XI, L.P.?
The percentage of profitable transactions made by Atlas Venture Fund XI, L.P. is 38%.
    What is the average return per transaction made by Atlas Venture Fund XI, L.P.?
    The average return per transaction made by Atlas Venture Fund XI, L.P. is -30.20%.
      What stocks does Atlas Venture Fund XI, L.P. hold?
      Atlas Venture Fund XI, L.P. holds: AKRO, DYN, DAWN, XLO, IKNA, THRD stocks.
        What was Atlas Venture Fund XI, L.P.’s latest transaction?
        Atlas Venture Fund XI, L.P. latest transaction was an Uninformative Sell of $19.63M.
          What was Atlas Venture Fund XI, L.P.'s most profitable transaction?
          Atlas Venture Fund XI, L.P.’s most profitable transaction was an Informative Buy of AKRO stock on June 25, 2019. The return on the trade was 39.40%.
            What is Atlas Venture Fund XI, L.P.'s role in Akero Therapeutics?
            Atlas Venture Fund XI, L.P.'s role in Akero Therapeutics is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.